An international phase II study of an all-oral combination of oral vinorelbine (NVBo) and capecitabine (X) in HER2-negative metastatic breast cancer (MBC)

被引：0
|
作者：
Tubiana-Mathieu, N.
Bougnoux, P.
Becquart, D.
Chan, A.
Majois, F.
Espie, M.
Aubert, D.
Villanova, G.
Conte, P. F.
机构：
[1] CHU Dupuytren, Limoges, France
[2] CHU Bretonneau, Tours, France
[3] AZ Middelheim, Antwerp, Belgium
[4] Mt Hosp, Perth, WA, Australia
[5] Hop Jolimont, Haine St Paul, Belgium
[6] Hop St Louis, Paris, France
[7] Inst Rech Pierre Fabre, Boulogne, France
[8] Policlin Modena, Modena, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1056
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of an all-oral combination of oral vinorelbine (NVBo) and capecitabine (X) in HER2-negative metastatic breast cancer (MBC): First results of an international phase II trial.
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Majois, F.
    Espie, M.
    Aubert, D.
    Bourlard, T.
    Villanova, G.
    Conte, P-F
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S280 - S280
  • [2] All-oral vinorelbine (NVBo) and capecitabine (X) combination for chemotherapy-naive HER2-negative metastatic breast cancer (MBC) patients: efficacy and safety in an international phase II study
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Majois, F.
    Espie, M.
    Palumbo, R.
    Llombart, A.
    Villanova, G.
    Conte, P. F.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 173 - 173
  • [3] AN INTERNATIONAL PHASE II STUDY OF AN ALL-ORAL COMBINATION OF ORAL VINORELBINE (NVBO) AND CAPECITABINE (X) IN HER2-NEGATIVE METASTATIC BREAST CANCER (MBC): LATEST RESULTS WITH A MEDIAN FOLLOW-UP OF 33.5 MONTHS
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Majois, F.
    Espie, M.
    Llombart, A.
    Villanova, G.
    Conte, P.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 68 - 68
  • [4] All-oral combination of oral vinorelbine (NVBo) and capecitabine (X) in HER2-negative metastatic breast cancer (MBC): latest results of a multicenter, international phase II trial with a median follow-up of 37.7 months.
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Majois, F.
    Espie, M.
    Morand, M.
    Vaissiere, N.
    Villanova, G.
    Conte, P-F
    [J]. CANCER RESEARCH, 2009, 69 (02) : 385S - 385S
  • [5] Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC)
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Majois, F.
    Espie, M.
    Perrot, O.
    Villanova, G.
    Conte, P. F.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 223 - 223
  • [6] All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial
    Tubiana-Mathieu, N.
    Bougnoux, P.
    Becquart, D.
    Chan, A.
    Conte, P-F
    Majois, F.
    Espie, M.
    Morand, M.
    Vaissiere, N.
    Villanova, G.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 101 (02) : 232 - 237
  • [7] All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial
    N Tubiana-Mathieu
    P Bougnoux
    D Becquart
    A Chan
    P-F Conte
    F Majois
    M Espie
    M Morand
    N Vaissiere
    G Villanova
    [J]. British Journal of Cancer, 2009, 101 : 232 - 237
  • [8] Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer
    Gampenrieder, Simon P.
    Bartsch, Rupert
    Matzneller, Peter
    Pluschnig, Ursula
    Dubsky, Peter
    Gnant, Michael X.
    Zielinski, Christoph C.
    Steger, Guenther G.
    [J]. BREAST CARE, 2010, 5 (03) : 158 - 162
  • [9] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Nole, Franco
    Crivellari, D.
    Mattioli, R.
    Pinotti, G.
    Foa, P.
    Verri, E.
    Fougeray, R.
    Brandely, M.
    Goldhirsch, A.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 673 - 680
  • [10] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Franco Nolè
    D. Crivellari
    R. Mattioli
    G. Pinotti
    P. Foa
    E. Verri
    R. Fougeray
    M. Brandely
    A. Goldhirsch
    [J]. Cancer Chemotherapy and Pharmacology, 2009, 64 : 673 - 680
12345